my country still lacks 130,000 bottles of treating hemophilia every year
Release time: 2010-04-19 & nbsp & nbsp & nbsp Source:
At present, Mainland my country can produce 270,000 bottles of hemophilic drug coagulation factors per year，Calculated according to international standards，If it fully meets the clinical treatment of Stake Sports Bettingpatients stake betting appin mainland my country，There is still a shortage of 130,000 bottles。The Ministry of Health will continue to cooperate with relevant departments，Optimize the production and supply system of coagulation factor drugs，To fully meet the needs of patients with hemophilia patients。This is the reporter learned at the press conference held by the Ministry of Health on April 13th。
April 17th is the 21st "World Blood Friends Day"，According to expert estimates，At present, there are about 60,000 to 130,000 hemophilia patients in my country。
Hematomy disease is a hidden hemorrhagic hemorrhagic disease of X chromosome chain，According to statistics from international epidemic disease，The incidence of hemophilia is 1/5000 ~ 10000 (male)，Female patients are rare。At present, there is no root treatment method，Alternative therapy such as infusion plasma、Cold refueling、Coagulation factor ⅷ or ⅸ is effective treatment measures。Patients with hemophilia supplement the appropriate amount of coagulation factors，stake sports betting appIt can live and work like ordinary people。
stake betting appWith the improvement of the medical security system and the improvement of clinical diagnosis and treatment level，The demand for alternative treatment for patients with hemophilia is getting greater and greater，Make the supply of coagulation factor drugs more tense。Especially after 2007，Even the phenomenon of "one medicine is difficult to find" in individual places。
For this，The Ministry of Health and the State Food and Drug Administration actively coordinated coagulation factor ⅷ production enterprises to increase raw material plasma collection、Cold sedimentation allocation production and other measures to increase drug output。Last year's coagulation factor ⅷ output increased significantly compared with the same period of the previous two years，Can produce 270,000 bottles per year，The tight supply of drugs is relieved to a certain degree。
At present, there are 3 companies holding coagulation factors in the Mainland in my country，Including Shanghai Rice Company、Henan Hualan Biopharmaceutical Stake Sports BettingCo., Ltd. and Anhui Green Stake Sports BettingCross Company。It is expected that China Pharmaceutical Group is also expected to obtain coagulation factor ⅷ production approval number。
As a national hemophilia information management center，The Hematology Hospital of the Chinese Academy of Medical Sciences analyzes the basic situation of hemophilia patients and the supply of coagulation factor drugs，As of April 13 this year，Information from 3,916 patients with blood friends has been registered nationwide。
The Ministry of Health also announced 26 provinces (regions、City) Nearly 90 experts from the main diagnosis and treatment institutions of hemophilia are out of consultation time，and more experts from more experts will be published one after another，To facilitate patients with hemophilia for medical treatment。
April 17th is the 21st "World Blood Friends Day"，According to expert estimates，At present, there are about 60,000 to 130,000 hemophilia patients in my country。
Hematomy disease is a hidden hemorrhagic hemorrhagic disease of X chromosome chain，According to statistics from international epidemic disease，The incidence of hemophilia is 1/5000 ~ 10000 (male)，Female patients are rare。At present, there is no root treatment method，Alternative therapy such as infusion plasma、Cold refueling、Coagulation factor ⅷ or ⅸ is effective treatment measures。Patients with hemophilia supplement the appropriate amount of coagulation factors，stake sports betting appIt can live and work like ordinary people。
stake betting appWith the improvement of the medical security system and the improvement of clinical diagnosis and treatment level，The demand for alternative treatment for patients with hemophilia is getting greater and greater，Make the supply of coagulation factor drugs more tense。Especially after 2007，Even the phenomenon of "one medicine is difficult to find" in individual places。
For this，The Ministry of Health and the State Food and Drug Administration actively coordinated coagulation factor ⅷ production enterprises to increase raw material plasma collection、Cold sedimentation allocation production and other measures to increase drug output。Last year's coagulation factor ⅷ output increased significantly compared with the same period of the previous two years，Can produce 270,000 bottles per year，The tight supply of drugs is relieved to a certain degree。
At present, there are 3 companies holding coagulation factors in the Mainland in my country，Including Shanghai Rice Company、Henan Hualan Biopharmaceutical Stake Sports BettingCo., Ltd. and Anhui Green Stake Sports BettingCross Company。It is expected that China Pharmaceutical Group is also expected to obtain coagulation factor ⅷ production approval number。
As a national hemophilia information management center，The Hematology Hospital of the Chinese Academy of Medical Sciences analyzes the basic situation of hemophilia patients and the supply of coagulation factor drugs，As of April 13 this year，Information from 3,916 patients with blood friends has been registered nationwide。
The Ministry of Health also announced 26 provinces (regions、City) Nearly 90 experts from the main diagnosis and treatment institutions of hemophilia are out of consultation time，and more experts from more experts will be published one after another，To facilitate patients with hemophilia for medical treatment。
